This review examines evidence on changes in muscle mass with incretin-based therapies and focuses on current and emerging strategies to preserve and enhance skeletal muscle mass.
Rachel Quinn, PharmD, BCACP, AE-C, CDCES
Advertisement
Articles by Rachel Quinn, PharmD, BCACP, AE-C, CDCES
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Orforglipron Reduces Body Weight Up to 14% in Women at Every Stage of Menopause
2
New Evidence Positions Finerenone as Foundational Therapy Across the CKD Spectrum
3
OTC Guide: Thirty Years Strong
4
NK3 as a Drug Target: From Scientific Discovery to Guideline-Recognized Therapy
5